Bulletin from the annual general meeting in SciBase Holding AB (publ)
Comunicato Precedente
Comunicato Successivo
Information regarding the newly elected board members' education, experience, assignments and independence can be found on the Company's website https://investors.scibase.se/sv/bolagsstyrning/bolagsstammor.
For additional information, please contact:
Pia Renaudin, CEO
Phone: +46 732 069 802
E-mail: [email protected]
Certified Advisor (CA):
DNB Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: [email protected]
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. For press releases and financial reports visit: http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/bulletin-from-the-annual-general-meeting-in-scibase-holding-ab--publ-,c4165205
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/bulletin-from-the-annual-general-meeting-in-scibase-holding-ab-publ-302483621.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




